Voit Christiane | Department Of Dermatology Venerology And Allergy Charite-universitatsmedizin Berlin
スポンサーリンク
概要
- VOIT Christianeの詳細を見る
- 同名の論文著者
- Department Of Dermatology Venerology And Allergy Charite-universitatsmedizin Berlinの論文著者
関連著者
-
Voit Christiane
Department Of Dermatology Venerology And Allergy Charite-universitatsmedizin Berlin
-
VOIT Christiane
Department of Dermatology and Allergy, Melanoma Center
-
Schafer-hesterberg Gregor
Department Of Dermatology Venerology And Allergy Charite-universitatsmedizin Berlin
-
LUKOWSKY Ansgar
Department of Dermatology, Venerology and Allergy, Charite-Universitatsmedizin Berlin
-
STERRY Wolfram
Department of Dermatology, Venerology and Allergy, Charite-Universitatsmedizin Berlin
-
Sterry Wolfram
Department Of Dermatology Venerology And Allergy Charite-universitatsmedizin Berlin
-
Sterry Wolfram
Department Of Dermatology And Allergy Charite Berlin
-
Lukowsky Ansgar
Department Of Dermatology And Allergy Charite Universitatsmedizin-berlin
-
Lukowsky Ansgar
Department Of Dermatology Venerology And Allergy Charite-universitatsmedizin Berlin
-
Hofmann Maja
Department Of Dermatology And Allergy Melanoma Center
-
Gussmann Felix
Department Of Dermatology And Allergy Melanoma Center
-
Trefzer Uwe
Department Of Dermatology And Allergy Melanoma Center
-
Schicke Bernd
Department Of Biomedical Statistics Charite-universitatsmedizin
-
FRITSCH Andreas
Department of Dermatology and Allergy, Melanoma Center
-
BIESOLD Susanne
Department of Dermatology and Allergy, Melanoma Center
-
KUCHLER Ingeborg
Department of Biomedical Statistics, Charite-Universitatsmedizin
-
Biesold Susanne
Department Of Dermatology And Allergy Melanoma Center
-
Fritsch Andreas
Department Of Dermatology And Allergy Melanoma Center
-
Kuchler Ingeborg
Department Of Biomedical Statistics Charite-universitatsmedizin
著作論文
- Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients
- Impact of lymph node metastases on serum level of melanoma inhibitory activity in stage III melanoma patients